Treatment Patterns and Healthcare Resource Utilization of Patients With Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Claims Data Analysis

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired hematologic disorder commonly treated with complement inhibitors such as eculizumab, ravulizumab, and pegcetacoplan. This study aims to describe treatment patterns, healthcare resource utilization, and cost for newly diagnosed PNH patient...

Full description

Bibliographic Details

Published in:	Clinical and Applied Thrombosis/Hemostasis
Main Authors:	Denise Clayton PhD, Jason Shafrin PhD, Glorian Yen PhD, MPH, Soyon Lee PharmD, Lincy Geevarghese MD, Yulin Shi MS, Luyang He MS, Ying Shen MS, Anem Waheed MD, MPH
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-01-01
Online Access:	https://doi.org/10.1177/10760296231213073